International US-Cuba Normalization Conference Coalition
Stand with Cuba 🇨🇺!
In an article by key opinion leaders, the authors considered that the fast development and deployment of mRNA vaccines and adenovirus vectors against the disease continues to astound the global…
The principal investigator of the clinical trials, Arturo Chang, pointed out that as part of the studies, the levels of antibodies have been evaluated, which turned out to be higher…
Originally posted on ONCUBANEWS.com The head of the National Department of Primary Health Care of the MINSAP, María Elena Soto, explained that the vaccination was designed by population strata and…
Washington Post, By Anthony Faiola and Ana Vanessa HerreroMarch 29, 2021 at 6:00 a.m. EDT Cuban leader Fidel Castro vowed to build a biotech juggernaut in the Caribbean, advancing the…
The president of BioCubaFarma and the general director of the Finlay Vaccine Institute (IFV) gave an overview of the current state of Cuban vaccine candidates in the Mesa Redonda TV…
The study uses the Soberana 01 vaccine candidate, the first to receive authorization in Cuba for tests on human beings, and seeks to “stimulate protective levels of neutralizing antibodies against…
By Sergio Held CAJICA, Colombia – Cuba’s Finlay Institute of Vaccines is moving forward with Soberana 2, a domestically developed conjugate vaccine against SARS-CoV-2. This is the second vaccine under…